期刊文献+

检测人动脉瘤组织中肺炎衣原体特异性抗原的临床意义 被引量:7

Clinical Significance of Detecting Chlamydia Pneumoniae-Specific Antigen in Human Artery Atheroma Tissues
下载PDF
导出
摘要 目的 :探讨肺炎衣原体 (Cpn)特异性抗原与动脉瘤的关系。方法 :利用直接免疫荧光 (IF)方法检测新鲜 -冰冻或福尔马林 -固定标本中Cpn特异性抗原的存在。结果 :新鲜 -冰冻标本中Cpn特异性抗原的阳性率是 :腹主动脉瘤组为 83.0 % (15 /18) ,正常血管组 12 .5 % (1/ 8) ,P <0 .0 1。此外 ,用IF方法检测了 40例档案保存的石蜡包埋冠状动脉瘤标本和正常血管组织切片 ,Cpn特异性抗原检出率分别是 :87.5 % (35 / 40 )和 0 (P <0 .0 0 1)。结论 :Cpn特异性抗原的高检出率见于人动脉瘤体组织中 ,推测Cpn引起的动脉粥样硬化可能是形成人动脉瘤的病因之一。 Objective: To investigate the relationship between Cpn-specific antigen and artery atheroma. Methods: Fresh-frozen or formalin-fixed specimens were tested for the presence of Cpn-specific antigen using direct immunofluorescence (IF). Results: The positive rate of Cpn-specific antigen was 83.0%(15/18)in eighteen fresh-frozen abdominal artery atheroma specimens, and the positive rate for Cpn antigen was 12.5%(1/8)in eight fresh-frozen normal artery tissues, P <0.01. A total 40 archival paraffin-embedded coronary artery atheroma specimens were examined by IF, the positive rate for Cpn-specific antigen was 87.5%(35/40), and 10 formalin-fixed normal artery tissue sections were negative, ( P <0.001). Conclusion: A high prevalence of C. pneumoniae-specific antigen is found in artery atheroma, which suggest that atherosclerosis related to Cpn may be a possible causation of artery atheroma.
出处 《中国临床医学》 2001年第2期136-138,共3页 Chinese Journal of Clinical Medicine
基金 卫生部科研基金 (项目名称 :用动物模型评估肺炎衣原体对动脉粥样硬化的致病作用。批准号 :98-2 -12 0 )资助。
关键词 动脉瘤 动脉粥样硬化 肺炎衣原体 特异性抗原 直接免疫荧光 Artery atheroma Atherosclerosis Chlamydia pneumoniae Specific antigen Direct immunofluorescence
  • 相关文献

参考文献2

二级参考文献11

共引文献25

同被引文献56

  • 1李涛,许香广,蔡俊明,钟跃青,周志玉,张明,张国良,张旭.肺炎衣原体感染与急性冠脉综合征的相关性[J].中国误诊学杂志,2005,5(1):4-7. 被引量:3
  • 2Mazzoli S,Tofain N,Fantini A,et al.Chlamydia Pneumoniae Antibody response in patients with acute Myocardial infarctiom and their Follow-up[J].Am Heart J,1998,153 (1):15-20.
  • 3Dowell SF,Peeling RW,Boman J,et al.Standardijing Chlamydia Pneumoniae assay:Recommendation from the Centers for Disease Control and Prevention (USA) and the Laberatory Centre for Disease Control (Canada)[J].Clin Infect Dis,2001,33:492-503.
  • 4File TM,Bartlett JG,Cassell GH,et al.The Importance of Chlamydia Pneumoniae as a pathogen:The 1996 consensus conference onChlamydia Pneumoniae Infection[J].Infection Disease in ClinicalPractice,1997,6:28-31.
  • 5Grayston JT,Kuo CC,Campbell LA,et al.Chlamydia Pneamoniae SP.Nova for Chlamydia SP.Strain TWAR[J].Int J Sys Bacteriol,1989,39 (1):88-90.
  • 6Miyashita N,Fukawo H,Mouri K,et al.Seft-limiting Pneumoniae Due to Chlarnydia Pneumoniae[J].Internal Medicine,2005,44 (8):870-874.
  • 7Miyashita N,Fukano H,Okimoton,et al.Clinical Presentation of Community-aquired Chlamydia Pneumoniae Pneumonia in adults[J].Chest,2002,121:1776-1781.
  • 8Boman J,Allrd A,Dersson K,et al.Rapid Diagnonsis of respiratory Chlamydia Pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection[J].Infect Dis,1997,175:1523-1526.
  • 9Campbell LA,Ewand RO,Alison L,et al.Detection of Chlamydia Pneumoniae TWAR in human Coronary Altherectomy fissues[J].The journal of infections disease,1995,172:585-588.
  • 10Charlotte AG,James TS,Narendra NS,et al.Replication of Chlamydia Pneumoniae in Vitro in human Mecrophages,Endothelial Cells,and Aortic Artery Smoooth Muscle culh[J].Infection and Immunity,1996,64 (5):1614-1620.

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部